EUCTR2015-002533-22-DK
Active, not recruiting
Phase 1
Palliation of dyspnea with morphine in patients with interstitial lung disease - MORPHILD
Aarhus University Hospital0 sites36 target enrollmentJune 12, 2015
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Interstitial Lung disease
- Sponsor
- Aarhus University Hospital
- Enrollment
- 36
- Status
- Active, not recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •A diagnosis of interstitial lung disease (IPF, NSIP, RA\-ILS, Scl\-ILS, MCTD\-ILS, asbestosis, drug induced ILD, un classified ILD)
- •Dyspnea Medial Research Councils (MRC) dyspnea score \= 3
- •Informed written consent
- •Age \= 18 years
- •For fertile women: negative HCG before inclusion
- •For fertile and sexualle active persons: Secure birth control during the study period and the day after
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) no
- •F.1\.2\.1 Number of subjects for this age range 18
Exclusion Criteria
- •Treatment with morpine or morphne analogues
- •Allergy towards morphine
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Palliation of Dyspnea and Cough using Morphine in patients with Fibrotic Interstitial Lung DiseaseFibrotic Interstitial Lung DiseaseMedDRA version: 21.1Level: PTClassification code: 10022611Term: Interstitial lung disease Class: 100000004855Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]CTIS2023-503700-81-00Aarhus University Hospital110
Completed
Not Applicable
Phase I study of safety of morphine for dyspnea in patients with interstitial lung diseaseDyspnea in patients with interstitial lung diseaseJPRN-UMIN000016137on-Profit Organization JORTC12
Completed
Not Applicable
Change in level of dyspnea when oral morphine is administered to cancer patientsDyspnea in cancer patientsJPRN-UMIN000006570Central Japan Lung Study Group (CJLSG)80
Active, not recruiting
Phase 1
Opioids for severe Shortness of Breath in Chronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary Disease, COPDMedDRA version: 20.0 Level: PT Classification code 10009033 Term: Chronic obstructive pulmonary disease System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersTherapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]EUCTR2018-002466-39-NLniversity Medical Center Groningen60
Recruiting
Not Applicable
Morphine or Fentanyl for Refractory dyspnea in COPDchronic bronchitis and emphysema.COPD (Chronic Obstructive Pulmonary Disease)10006436NL-OMON52406niversitair Medisch Centrum Groningen60